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To our knowledge, this is the 1st study to 
evaluate and show the possible benefits 
of IC on reducing admission/ER visits for 
high-risk (CHF/COPD) patients in the 
HMO setting. Compared to conventional 
analytical and administrative models for 
unnecessary admissions, integrating new 
technologies to treat high-risk patients 
may deliver significant clinical benefits to 
healthcare in the 30-90 day setting.
Reducing unnecessary hospital admission/ER visits on 
HMO/MSO/ACO patients is very challenging beyond 
the traditional 30-90 day readmission threshold. Our 
study focused on expanding an Interreality (On-Site & 
On-Line) Care (IC) model (EHJ 2018;39:S225) in high-
risk patients in HMO setting.
Background
Conclusion
30-90 Day Benefit of Using Interreality Care to Reduce Unnecessary 
Hospital Admissions among High-Risk Patients
Methods
IC model was created by integrating:
1. On-Site Care: ARNP & testing at patients’ residency; 
2. On-Line Care: 24/7 monitoring & specialty 
cardiology/pulmonary intervention; and 
3. A new high-risk care system with telemedicine, 
device, monitoring, protocols & management. 
A group of 57 Medicare Advantage patients with 
multiple admission/ER visits from 3 different healthcare 
organizations were referred to a Management Service 
Organization (MSO) due to their increased diagnosis 
severity (CHF/COPD) & costs. 
Of the 57 patients, 11 patients were lost to follow-up 
prior to enrollment (n=46). Baseline admission/ER visits 
were determined on conventional care provided prior to 
enrollment. Of the 46 enrolled patients, admission/ER 
visits were normalized by total days of baseline and 
compared between conventional care (CC) and IC. 
Patients in IC were treated and followed on average for 
70 days (70 ± 33 days).
Prior to IC, patients with CC had 277 total admission/ER visits compared to 14 during IC. 
Of the 46 enrolled patients, IC showed a 80% decrease for ALL admission/ER visits 
compared to CC (0.3 ± 0.8 IC vs. 1.5 ± 1.2 CC; p < 0.001*) with a decrease in average 
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